RNAÐÞÊÎÒþ²ØµÄÉñÃØµ÷¿Ø
2016ÄêµÄ×îºóÒ»Ì죬Nature Methods¸Ï×Å·¢²¼ÁË2016Äê¶È¼¼Êõ£¬²»ÉÙÈËÈÏΪµ±ÄêµÄÄê¶È¼¼ÊõÒ»¶¨ÊÇ´ó»ðµÄCRISpR¼¼Êõ£¬È»²¢ÂÑ£¬¶ÔÓÚÆÄ¾ßǰհÐÔµÄÄê¶È¼¼ÊõÅ̵ãÀ´Ëµ£¬Ò»¸ö²¢²»³£¼ûµÄÃû´Ê£ºEpitranscriptome analysis£¨±í¹Ûת¼×éѧ£©²ÅÊÇÕý½â¡£
Epitranscriptome analysisÕâ¸öÃû³ÆÊÇÓÉÏ£À°Óï¡°epi¡±×÷Ϊǰ׺£¬Ö¸µÄ¾ÍÊdzý¿ªÒÑÖª¹¦ÄÜ»òÒÅ´«ÐÔ£¬ÈκÎÌí¼Óµ½ºËÜÕËáÉϵÄÐÞÊΡ£¼¸Ê®ÄêÀ´£¬¿ÆÑ§¼ÒÃǼ¸ºõ¶¼Ã»ÓÐ×¢Òâµ½RNAÐÞÊΣ¬ÒòΪÔçÔÚÉϸöÊÀ¼Í60Äê´úºÍ70Äê´úRNAÉϵıê¼Ç¾Í±»·¢ÏÖÁË£¬µ«ÊÇ´ó¼ÒÖ»¹Ø×¢ÓÚtRNAºÍrRNA£¬ÒÔ¼°DNAÉϵıí¹ÛÒÅ´«ÐÞÊΡ£
µ«Ëæ×Å¿ÆÑ§¼ÒÃÇ·¢ÏÖÁ˳öÏÖÔÚËùÓÐRNAÖÖÀàÖеĻ¯Ñ§±ê¼Ç£¬¶¯Ì¬Ìí¼Ó»òÕßÈ¥³ýÕâЩ±ê¼ÇµÄ¡°ReaderдÊÖ¡±ºÍ¡°EraserÏðÆ¤²Á¡±£¬ÖØÐµãȼÁ˶ÔRNAÐÞÊεÄÐËȤ¡£ÀýÈ磬´ÓÏÙàÑßÊÉÏÈ¥³ýÒ»¸ö¼×»ù»ùÍŵÄø£¬Óë°¢¶û´Äº£Ä¬Ö¢»¼²¡·çÏÕÖ®¼äµÄ¹ØÁª£¬±íÃ÷ÁËÕâÖÖÐÞÊÎÔÚÉñ¾½¡¿µ·½Ãæ°çÑÝÁËÖØÒªµ÷½Ú×÷Óá£
Óɴ˱í¹Ûת¼×éѧԽÀ´Ô½Êܵ½¿ÆÑ§¼ÒÃǵÄÖØÊÓ£¬³ÉΪÁ˽üÀ´ÐËÆðµÄÈÈÃÅÁìÓòÖ®Ò»¡£Æù½ñΪֹ£¬ÔÚRNAÉÏÒÑ·¢ÏÖÁË170¶àÖÖ»¯Ñ§ÐÞÊÎ[1]¡£ÕâЩÐÞÊδóÁ¿·Ö²¼ÔڷDZàÂëRNA£¨ncRNA£©£¬ÌرðÊÇrRNA, tRNAºÍsnRNAÉÏ£¬ÎªncRNAÔÚ·ÒëÓë¼ô½ÓÖз¢»ÓÕý³£¹¦ÄÜËù±ØÐè¡£ÁîÈËÐ˷ܵÄÊÇ£¬Ñо¿ÈËÔ±·¢ÏÖm6A£¨N6-methyladenosine£©£¬m1A£¨N1-methyladenosine£©£¬m5C£¨5-methylcytidine£©£¬hm5C£¨5-hydroxylmethylcytidine£©£¬I£¨inosine£©ÒÔ¼°¦×£¨pseudouridine£©µÈ»¯Ñ§ÐÞÊÎÒ²·Ö²¼ÔÚÕæºËÉúÎïmRNAÉÏ£¬Ó°ÏìmRNAµÄ´úлÓ빦ÄÜ¡£ÌرðÊǰéËæ×ÅÐí¶àmRNAÐÞÊÎø£¨Writer£©¡¢È¥ÐÞÊÎø£¨Eraser£©ºÍÐÞÊÎʶ±ðµ°°×£¨Reader£©µÄз¢ÏÖ£¬mRNA»¯Ñ§ÐÞÊεĿÉÄæ±ä»¯Ó붯̬µ÷¿ØÖØÐ¼¤ÆðÁËÑо¿ÈËÔ±µÄÐËȤ¡£
ͼһÀ´×Ô[2]
±í¹Ûת¼×éѧÑо¿·¶Î§
±í¹Ûת¼×éѧ£¨epitranscriptomics£¬Óֳơ°RNA±í¹ÛÒÅ´«Ñ§¡±£©ÊÇָת¼ºó RNA ÐÞÊΣ¬ÕâЩÐÞÊθø×ªÂ¼×é´øÀ´Á˹¦ÄÜÏà¹ØµÄ±ä»¯¡£±í¹Ûת¼×éÐÞÊΰüÀ¨¼¸¸öÖØÒªµÄ RNA ¼Ó¹¤Ê¼þ£¬°üÀ¨ RNA ±à¼¡¢¼×»ù»¯ºÍ¼ô½Ó£¨Í¼¶þ)¡£
ͼ¶þÀ´×Ô[4]
´ÓÊÇ·ñ±àÂëµ°°×ÖÊÀ´Ëµ£¬RNA¿ÉÒÔ·ÖΪ±àÂëRNA£¨coding RNA£©ÐÞÊκͷDZàÂëRNA£¨non-coding RNA, ncRNA£©Á½´óÀࡣǰÕß¾ÍÊÇÖ¸mRNA£¬ºóÕßÔò°üÀ¨ºÜ¶àÖÖÀ࣬ÈçÖÚËùÖÜÖªµÄtRNAºÍrRNA£¬²ÎÓëRNAÐÞÊεÄsnoRNAµÈ¡£
mRNAÐÞÊÎÑо¿×î¶àµÄ¾ÍÊÇm6A ÐÞÊΣ¬ÔçÔÚ 20 ÊÀ¼Í 70 Äê´ú£¬¿ÆÑ§¼ÒÃǾÍÔÚ RNA Öз¢ÏÖÁË m6A ÐÞÊΣ¬ËæºóÔ½À´Ô½¶àµÄÑо¿Ö¤Ã÷m6A ÐÞÊεÄÖØÒªÐÔ£ºm6A ÐÞÊÎºÍ mRNA µÄÎȶ¨ÐÔ¡¢¼ô½Ó¼Ó¹¤¡¢·ÒëÒÔ¼° microRNA µÄ¼Ó¹¤Óйأ»m6A »¹ºÍ¸Éϸ°ûÃüÔË¡¢ÉúÎï½ÚÂÉÏà¹Ø£¬¿ÉÒÔ´Ùʹ¸Éϸ°û´Ó×ÔÎÒ¸üÐÂ״̬תÏòϸ°û·Ö»¯£¬Ñо¿ÈËÔ±·¢ÏÖ£¬¼×»ù»¯»áËõ¶Ì mRNA µÄ°ëË¥ÆÚ£¬¼õÉÙÆä·á¶È¡£¿ÉÒÔ˵£¬m6A ÐÞÊμ¸ºõÓ°Ïì RNA ´úлµÄÿ¸ö²½Öè¡£
¶ø½üÄêÀ´£¬Ëæ×ÅÑо¿µÄÉîÈ룬²»ÉÙÑо¿¹¤×÷Ò²´ÓmRNAתΪ¹Ø×¢·Ç±àÂëRNAµÄ¼×»ù»¯¶ÔÓÚ¼²²¡·¢Éú·¢Õ¹¹ý³ÌµÄÖØÒª×÷Ó㬷¢ÏַDZàÂëRNAµÄm6A¼×»ù»¯»áÔÚ¸Éϸ°û·Ö»¯¡¢°©Ï¸°ûÔöÖ³µÈ¹ý³ÌÖÐÆð¹Ø¼ü×÷Óá£Í¬mRNAÒ»Ñù£¬lncRNAÉÏÒ²´æÔÚ×ŶàÖÖ»¯Ñ§ÐÞÊΣ¬m6A¼×»ù»¯¶ÔÓÚlncRNAÀ´½²£¬¿ÉÒÔµ÷¿ØlncRNA¶þ¼¶½á¹¹£¬lncRNA½áºÏµ°°×£¬ÒÔ¼°lncRNAµÄceRNA»úÖÆ£¬°Ð»ùÒòµÄm6AÐÞÊΡ£
´ËÍ⻹Óл·×´RNAÉÏm6AÐÞÊΣ¬ÕâÄÜÓ°ÏìcircRNAºÍRNA½áºÏµ°°×(RBp)Ö®¼äµÄÏ໥×÷Óã¬ÒÔ¼°±ê¼ÇÄÚÔ´RNA£¬´Ó¶ø½«ÆäÓëÍâÔ´RNAÇø·Ö¿ª£¬±ÜÃâ±»×ÔÉíÃâÒßϵͳʶ±ð¹¥»÷¡£
Small RNA£¬ÀýÈçmicroRNA£¬tRNAÀ´Ô´Ð¡RNA(tsRNA£¬°üÀ¨tRF&tiRNA)µÈ£¬ÆäRNA·Ö×ÓÉϾßÓжàÖÖ²»Í¬µÄÐÞÊΣ¬ÕâЩÐÞÊÎÒ»·½ÃæÄܹ»µ÷¿Øsmall RNAµÄ»îÐÔ£¬ÁíÒ»·½ÃæÒ²¿ÉÒÔ¸³ÓèËüÃÇÐµĹ¦ÄÜ¡£ÒÑÖªÕâЩRNAÐÞÊÎͨ¹ý¶àÖÖ·Ö×Ó»úÖÆÀ´·¢»Ó¹¦ÄÜ£¬ÈçRNAÐÞÊοÉÒԸıämiRNAµÄ°ÐÏòÐÔ»ò¸Ä±ätsRNA(tRF&tiRNA)ÓëRNA½áºÏµ°°×µÄÇ׺ÍÁ¦£¬½ø¶ø·¢»ÓÉúÎï»îÐԵȡ£Small RNAÐÞÊÎÆ×·ÖÎöÊDZí¹Ûת¼×éѧÑо¿µÄÐÂÇ°ÑØ£¬¾ßÓÐÖØÒªµÄ¿ÆÑ§ÒâÒåºÍÁÙ´²¼ÛÖµ¡£
RNA ÐÞÊÎÁìÓò×îÖØÒªµÄ³É¾Í
¶ÔÓÚÆù½ñΪֹRNAÐÞÊÎÁìÓò×îÖØÒªµÄ³É¾Í£¬¿µÄζû´óѧSamie R. Jaffrey½ÌÊÚÈÏΪ£¬¡°µÚÒ»¸öÓÃÓÚ»æÖÆ m6Aȫת¼×é·½·¨¿ÉÄÜÊDZí¹Ûת¼×éѧÁìÓòÖÐ×îÖØÒªµÄʼþ£¬ÏÖÔÚÒѾ±»¸´ÖÆÓÃÓÚÆäËû¼¸ÖÖºËÜÕËáÐÞÊΡ£ ÔÚȫת¼×é×÷ͼ֮ǰ£¬Í¨¹ýʹÓÃÖÊÆ×·¨»òÆäËû·ÖÎö²âÁ¿¼ì²âË®½â RNA ÖÐÐÞÊεĺËÜÕËᣬ·¢ÏÖÐÞÊεĺËÜÕËá¡£ÕâЩ·½·¨ÊÇÄ£ÀâÁ½¿ÉµÄ£¬ÓÈÆäÊǶÔÓڵͷá¶ÈµÄÐÞÊΣº¼´Ê¹ÄãÓÐÒ»¸ö¸ß´¿¶ÈµÄ mRNA ÖÆ¼Á£¬Ä㻹Êǵ£ÐÄ΢Á¿µÄÎÛÈ¾×ªÒÆ RNA (tRNA) »òºËÌÇÌå RNA (rRNA) ¿ÉÄÜÊÇÐÞÊεÄÀ´Ô´¡£ÕâʹµÃºÜÄÑÈ·¶¨ÐÞÊεĺËÜÕËáÊÇ·ñÀ´×Ô mRNA¡£¡±
ÒÔÉ«ÁÐÌØÀά·ò´óѧҽѧԺµÄGideon Rechavi½ÌÊÚÔò±íʾ£¬¡°ÔÚÎÒ¿´À´£¬¸ÃÁìÓòµÄÖ÷Òª³É¾ÍÊÇͨ¹ýmRNA ÐÞÊνÒʾÁËÒ»¸öеġ¢¸´Ôӵġ¢¸ß¶ÈÃô¸ÐµÄ¡¢¿Éµ÷½ÚµÄ»ùÒò±í´ïµ÷¿Ø²ã¡£Õâһеĵ÷¿Ø²ãÀûÓÃÁËmRNA µÄ¶ÀÌØÌØÐÔ¡ª¡ª¼´ËüÊǶÌÔݵġ¢¸ß¶È½á¹¹»¯µÄ¡¢ÔÚϸ°ûÇøÊÒÖ®¼äÒÆ¶¯²¢Í¨¹ýת¼·Å´óµÄ¡£ÕâЩӰÏ첿·ÖÊÇÓÉ¡°ÔĶÁÆ÷¡±½éµ¼µÄ£¬ÀýÈç¼×»ùÌØÒìÐÔ½áºÏµ°°×£¬ËüµÄ¼ø¶¨ÊÇÐÞÊÎÁìÓòµÄÒ»¸öÀï³Ì±®¡£»ùÒò±í´ïµÄµ÷½ÚҲͨ¹ý¡°Ð´ÊÖ¡±ºÍ¡°ÏðÆ¤²Á¡±µÄÐ޸ݲװºÍɾ³ýÖ®¼äµÄÏ໥×÷ÓýøÐе÷Õû¡£ÔÚ¹ýÈ¥µÄÊ®ÄêÖУ¬³öÏÖÁ˼¸¸öÖØÒªµÄ½Ìѵ¡£Ê×ÏÈ£¬mRNA ÐÞÊηdz£ÆÕ±é£¬Êýǧ¸ö»ùÒòת¼±¾±»ÐÞÊΡ£ÓÐȤµÄÊÇ£¬Ò»Ð©Ð޸ľۼ¯ÔÚÌØ¶¨µÄת¼λÖã»ÀýÈ磬¼¡ÜÕÖ÷Òª´æÔÚÓÚÖØ¸´µÄ Alu ÐòÁÐÖУ¬m6A ÓÅÏÈÐÞÊÎÖÕÖ¹ÃÜÂë×Ó¸½½üºÍÄÚ²¿ÍâÏÔ×Ó¡¢ AUG ÆðʼÃÜÂë×ÓÖÜΧµÄ m1A ´Ø£¬Õâ±íÃ÷ÿ¸öÐÞÊÎͨ¹ý²»Í¬µÄģʽÆð×÷ÓÃÐж¯¡£´ËÍ⣬һЩÐÞÊΣ¬Èç m6A ºÍ m1A£¬ÔÚÈ˺ÍСÊóÖ®¼ä±íÏÖ³ö¸ß¶ÈµÄ±£ÊØÐÔ¡£
ÁíÒ»¸öÖØÒªµÄ³É¾ÍÊÇ·¢ÏÖÌØ¶¨µÄÐ޸ĿÉÒÔͨ¹ý²»Í¬µÄÐÐΪģʽ£¬Í¨¹ý²»Í¬µÄ¶ÁÈ¡£¬ÒÀÀµÓÚÉÏÏÂÓΡ£»¹ÓÐÒ»¸öÖØÒª·¢ÏÖÊÇһЩ mRNA ÐÞÊεĶ¯Ì¬ÌØÐÔ£¬¿ÉÒÔ¶Ô»·¾³´Ì¼¤×ö³ö¿ìËÙ·´Ó¦£» m6A ºÍ m1A ÒѾ֤Ã÷ÁËÕâÖÖ¶¯Ì¬ÌØÐÔ¡£ mRNA ÐÞÊεĺËÐÄ×÷ÓÃÌåÏÖÔÚÒì³£ÐÞÊζÔÈËÀàºÍСÊóÔçÆÚ·¢ÓýÒÔ¼°ÈËÀà°©Ö¢¡¢Ñ×Ö¢ºÍÉñ¾±äÐÔµÄÆÆ»µÐÔÓ°Ï죬½øÒ»²½Ç¿µ÷ÁËÕâÒ»µ÷½Ú²ãµÄÖØÒªÐÔ¡£¡±
¶«¾©´óѧµÄTsutomu Suzuki½ÌÊÚ±íʾ£¬¡°ÒÔǰ¹ØÓÚ RNA ÐÞÊεÄÉú»¯Ñо¿Ö÷Òª¼¯ÖÐÔÚ¾µäµÄ·Ç±àÂë RNA£¬°üÀ¨ tRNA¡¢rRNA ºÍСºË RNA (snRNA)£¬ÒòΪÕâЩRNA ÔÚϸ°ûÖк¬Á¿·á¸»¡£È»¶ø£¬×î½ü£¬Ê¹Óà NGS ¼¼Êõ¶Ô RNAÐÞÊνøÐÐȫת¼×é·ÖÎöÒѶ¨³ö¼¸ÖÖ¼î»ùÐÞÊΣ¬°üÀ¨ mRNA Öеļ¡ÜÕ (I)¡¢m6A¡¢m5C¡¢¦· ºÍ m1A ÒÔ¼°³¤Á´·Ç±àÂë RNA¡£Õâ·´¹ýÀ´Õâ´ó´óÍØ¿íÁ˱í¹Ûת¼×éµÄ¸ÅÄî¡£
ÔÚ¹ýÈ¥µÄÊ®¼¸ÄêÖУ¬Í¨¹ý·´ÏòÒÅ´«Ñ§ºÍÖÊÆ×·¨£¬¿ÆÑ§¼ÒÃÇʶ±ð³öÁËÂñ²ØÔÚģʽÉúÎï»ùÒò×éÖеÄRNA ÐÞÊÎø¡£Ê¹ÓÃÕâÖÖ·½·¨£¬ÎÒÃdzɹ¦¼ø¶¨ÁË 40 ¸öRNA ÐÞÊλùÒò¡£
»¹ÖµµÃÒ»ÌáµÄÊÇ£¬Óë¼²²¡Ïà¹ØµÄÍâÏÔ×Ó×é²âÐòÓÐÖúÓÚ½âÎöRNA ÐÞÊÎøͻ±äÈçºÎÒý·¢ÁËÐí¶àÈËÀ༲²¡¡£¡±[5]
ÈçºÎÑо¿RNAÐÞÊÎ
´ÓĿǰµÄÑо¿³É¹ûÀ´¿´£¬±í¹Ûת¼×éÓ°ÏìÉîÔ¶£¬ÊÇ×÷Ϊ½«¿ÉËÜÐÔµþ¼ÓÔÚÆäËû»ùÒò×éÉÏÁ¬Ïßת¼×éÉϵÄÒ»ÖÖÊֶΡ£±í¹Ûת¼×é¡°´úÂ롱²»½ö¿ÉÒÔÆôÓûòÔöÇ¿ RNA ´ß»¯»ò RNA ÒÀÀµÐÔ·´Ó¦ÖеÄÌØ¶¨»¯Ñ§·´Ó¦£¬»¹¿ÉÒԸıä RNA ½á¹¹-¹¦ÄܹØÏµ£¬´Ó¶øÒÔʱ¿ÕºÍÐźÅÒÀÀµÐÔ·½Ê½Ìṩ¶îÍâµÄ»ùÒòµ÷¿Ø²ã¡£
È»¶ø£¬±í¹Ûת¼×éµÄ¹¦ÄÜÑо¿ÂäºóÓÚ±í¹Û»ùÒò×éµÄ¹¦ÄÜÑо¿£¬ÕâÊÇÒòΪȱ·¦¿ÉÒÔÔÚת¼×鷶ΧÄÚ¼ì²âÕâЩ±í¹Ûת¼×é±ê¼ÇµÄÁéÃôÇÒÎȽ¡µÄ¼¼Êõ¡£Ñо¿±í¹Ûת¼×é´æÔÚ¼¸¸öÖ÷ÒªÌôÕ½¡£Ê×ÏÈ£¬´ó¶àÊý RNA ÐÞÊβ»ÄÜͨ¹ý¸ßͨÁ¿²âÐòÖ±½Ó¼ì²âµ½¡£ÒòΪ¶Ô RNA µÄ»¯Ñ§ÐÞÊÎͨ³£²»»á¸Ä±äÐÞÊμî»ùµÄ¼î»ùÅä¶ÔÌØÐÔ£¬Äæ×ªÂ¼ (RT) ½«¼òµ¥µØ²Á³ýÕâЩÐÞÊΣ¬²¢Ê¹ËüÃÇÓë³£¹æ RNA ¼î»ùÎÞ·¨Çø·Ö¡£Æä´Î£¬ËäÈ» rRNA¡¢tRNA ºÍ snRNA ºÜ·á¸»£¬µ«ÆäËûÀàÐ͵ÄRNA£¬ÀýÈç mRNA ºÍ³¤Á´·Ç±àÂë RNA (lncRNA)£¬·á¶È¿ÉÄܽϵ͡£µÚÈý£¬È±·¦ÏÖÓеļÆË㹤¾ßÀ´´Ù½ø´Ó²âÐòÊý¾Ýʶ±ðÐÞÊÎλµãµÄÄÜÁ¦¡£
ÐÒÔ˵ÄÊÇ£¬½üÄêÀ´£¬Õë¶Ô²»Í¬±í¹Ûת¼×éµÄÑо¿·½·¨È¡µÃÁËÖØ´ó½øÕ¹¡£ÕâЩй¤¾ß°ïÖúÑо¿ÈËԱȷ¶¨ RNA ÐÞÊεÄλÖ㬲¢½ÒʾÕâЩÐÞÊÎÔÚÕû¸öת¼×éÖеIJ»Í¬·Ö²¼Ä£Ê½¡£µ±ÕâЩ·½·¨ÓëÆäËûÐÂÐ˹¤¾ß£¨ÀýÈç»ùÒò×é±à¼¹¤¾ß£©½áºÏʹÓÃʱ£¬RNA ÐÞÊÎøµÄ°Ð±ê¾ÍÒÑÈ·¶¨¡£´ËÍ⣬ÕâЩ¼¼Êõ»¹½ÒʾÁ˲»Í¬ÉúÀíÌõ¼þϲ»Í¬±í¹Ûת¼×é±ê¼ÇµÄ¶¯Ì¬ÐÔÖÊ¡£Í¬Ê±ÕâЩ¹¤¾ßʹÈËÃÇÄܹ»·¢ÏÖÑ¡ÔñÐÔʶ±ðÌØ¶¨±í¹Ûת¼×é±ê¼Ç²¢È·¶¨Æä¹¦Äܵġ°ÔĶÁÆ÷¡±µ°°×¡£Òò´Ë£¬ÐµÄÑо¿¹¤¾ß²»½ö¿ÉÒÔ¶Ô±í¹Ûת¼×é½øÐÐÈ«Ãæ·ÖÎö£¬¶øÇÒ»¹Êǹ¦Äܱí¹Ûת¼×éÑо¿µÄ±¦¹ó×ÊÔ´ [2]¡£
¢Å ¼ì²â·ÖÎö·½·¨
Ñо¿ RNA ÐÞÊεķ½·¨°üÀ¨ÊÇÒºÏàÉ«Æ×(LC-MS) ¡¢»ùÓÚ¸ßͨÁ¿²âÐòµÄ·½·¨ºÍоƬ·ÖÎöµÈ·½·¨¡£
¢Ù mRNA&lncRNA±í¹Ûת¼×éоƬ
RNAÐÞÊεÄDZÔÚ¹¦Äܲ»½öÈ¡¾öÓÚÆäËùÐÞÊεÄÊǺÎÖÖ»ùÒòת¼±¾£¬Í¬Ê±Ò²È¡¾öÓÚ±»ÐÞÊβ¿·ÖÔÚ¸Ãת¼±¾ÖÐËùÕ¼µÄ°Ù·Ö±È¡£È»¶ø£¬Ä¿Ç°´ó²¿·Öת¼×éˮƽµÄµÄRNAÐÞÊμì²â·½·¨×ÅÖØÓÚѰÕÒת¼±¾ÉϵÄÐÞÊÎλµã£¬²»Äܹ»¶¨Á¿µØ¼ì²â±»ÐÞÊÎת¼±¾µÄ°Ù·Ö±È¡£ÕâÒ»ÀඨÁ¿ÐÅÏ¢µÄȱ·¦ÒÑÒýÆðÔ½À´Ô½¶à¿ÆÑй¤×÷ÕߵĹØ×¢¡£
mRNAÐÞÊεÄDZÔÚÓ°Ïì¼ÈÈ¡¾öÓÚÆä·Ö×ÓЧӦ£¬Ò²È¡¾öÓÚ±»ÐÞÊÎת¼±¾µÄ°Ù·Ö±È¡£ÀýÈ磬һÖÖ¿ÉÒÔ¼ÓËÙmRNA½µ½âµÄÐÞÊΣ¬Èç¹ûÖ»ÓÐ1%µÄת¼±¾±»ÐÞÊΣ¬ÏÔÈ»²»Ì«¿ÉÄܲúÉúÈκÎÉúÎ﹦ÄÜ£¬È»¶øµ±Ò»ÖÖÐÞÊοÉÒÔ´ÙʹmRNA·Òë³Éеĵ°°×ÑÇÐÍʱ£¬¼´Ê¹ÐÞÊÎˮƽºÜµÍ£¬Ò²¿ÉÄܲúÉúÖØÒªµÄÉúÎ﹦ÄÜ¡£µ±Ç°µÄm6AºÍ¦·¼ì²â·½·¨¾ÖÏÞÐÔÔÚÓÚȱ·¦ÐÞÊγ̶ȵ͍Á¿ÐÅÏ¢¡£m6AµÄµ÷¿Ø×÷ÓÿÉÒÔͨ¹ýpulldown m6AµÄ·½·¨£¬¼ì²âÌØ¶¨ÐòÁÐÔÚ²»Í¬×´Ì¬ÏµÄÏà¶Ô¸»¼¯³Ì¶È½øÐÐÍÆ¶Ï£¬µ«²»ÄÜ´ÓÕâЩÊý¾ÝÖлñµÃ±»ÐÞÊÎmRNAµÄ¾ø¶ÔÁ¿¡£ÐµĿɶ¨Á¿m6AºÍ¦·µÄ¸ßͨÁ¿¼ì²â·½·¨£¬½«¼«´óµÄ´Ù½ø¸ÃÁìÓòµÄ·¢Õ¹[7]¡£
ÁíÒ»¸öÖØÒªµÄÎÊÌâÊDzûÃ÷RNAÐÞÊεĻ¯Ñ§¼ÆÁ¿µÄ¶¯Ì¬±ä»¯¡£Ä¿Ç°£¬±í¹Ûת¼×éѧÑо¿µÄÖØµã´ó¶àÊÇÄÄЩλµã±»ÐÞÊΣ¬¶ø²»ÊÇRNAÖÐÿ¸ö±»ÐÞÊÎλµãµÄÕ¼±È¡£µÍͨÁ¿·ÖÎömRNAºÍ²¡¶¾RNAµÄm6AÐÞÊÎλµãÏÔʾ£¬ÈκÎm6AÐÞÊÎλµãµÄÕ¼±È¶¼²»»á´ïµ½100%¡£ÐÞÊεĻ¯Ñ§¼ÆÁ¿±ä»¯¿ÉÄÜÊÇÒ»ÖÖRNAÉúÎïѧÐÞÊεĶ¯Ì¬±ä»¯²ÎÊý¡£ÐÞÊοÉÒÔÓ°ÏìmRNAµÄ½á¹¹£¬ºÍ£¨»ò£©¶ÔRBpsµÄÕÐļ¡£ÈκÎÌØÊâλµãµÄÐÞÊΣ¬»áµ¼ÖÂͬһmRNAȺÌå½ö½öÓÉÓڽṹ»òÊǽáºÏreaderµÄ²»Í¬£¬·ÖΪÁ½¸ömRNAÑÇȺ¡£Òò´Ë£¬¸Ä±äÐÞÊεĻ¯Ñ§¼ÆÁ¿Êý£¬¿ÉÄÜÊÇͬһ¸öRNAת¼±¾ÐÐʹ²»Í¬¹¦ÄܵÄÒ»ÖÖ»úÖÆ¡£Ä¿Ç°¼±Ðè¿ÉÒÔ¼ì²âÐÞÊλ¯Ñ§¼ÆÁ¿ÊýµÄ¸ßͨÁ¿·½·¨£¬ÒÔ²ûÃ÷±í¹Ûת¼×éѧÔÚÕâÒ»·½ÃæµÄÎÊÌâ[8]¡£
Arraystar mRNA&lncRNA±í¹Û¹Ûת¼×éоƬ½áºÏÁË˫ӫ¹âͨµÀоƬ¼¼ÊõÓëRNAÐÞÊÎÃâÒß¹²³Áµí¼¼Êõ£¬ÔÚת¼±¾Ë®Æ½¶ÔRNAÐÞÊνøÐж¨Á¿¼ì²â¡£¶¨Á¿µÄ±í¹Ûת¼×éͼÆ×¿ÉΪRNAÐÞÊε÷¿ØÑо¿Ìá¹©ÖØÒªÐÅÏ¢¡£
´ËÍ⣬»¹ÓÐArraystar small RNAÐÞÊÎоƬ£¬¿µ³ÉÌṩµÄÏà¹Ø¼¼Êõ·þÎñÔÚµ¥ÕÅоƬ¿É¶¨Á¿miRNA£¬pre-miRNAºÍtRNAÑÜÉúµÄsmall RNA£¨tsRNA£¬°üÀ¨tRF£¦tiRNA£©µÄ¼î»ùÐÞÊΡ£¿É¼ì²âµÄÐÞÊΰüÀ¨£º8-Ñõ´úÄñàÑßÊ£¨o8G£©£¬7-¼×»ùÄñÜÕ£¨m7G£©£¬N6-¼×»ùÏÙÜÕ£¨m6A£©£¬¼ÙÄòÜÕ£¨¦·£©»ò5-¼×»ù°ûÜÕ£¨m5C£©¡£
Ë÷È¡¿µ³ÉÉúÎïArraystar ±í¹Ûת¼×éоƬ
¢ÚÒºÏàÉ«Æ×-ÖÊÆ×·¨
LC-MS ÊÇÒ»ÖÖÇ¿´óµÄ¼¼Êõ£¬ÄÜÒÔ³öÉ«µÄÁéÃô¶ÈºÍ¸ßÌØÒìÐÔ¼ì²âÐÞÊιýµÄRNAºËÜÕ¡£È»¶ø£¬ÔÚ²âÁ¿ mRNA ÐÞÊεı³¾°Ï£¬ÓÐÁ½¸ö¹Ø¼üÏÞÖÆ¡£
Ê×ÏÈ£¬LC-MS ½øÐÐλµãÌØ¶¨¼ì²âµÄÄÜÁ¦ÓÐÏÞ¡£ÔÚ mRNA µÄ±³¾°Ï£¬Æù½ñΪֹ£¬MS ½öÊÊÓÃÓÚÍêÈ«Ïû»¯µÄºËÜÕ£¬Òò´ËÄܹ»¹À¼ÆÑùÆ·ÖÐÐÞÊεġ°ÕûÌ塱ˮƽ£¬µ«ÅųýÁ˽«¸ÃÐÞÊηÖÅäµ½µ¥¸öλµãµÄ¿ÉÄÜÐÔ¡£µ±Ó¦ÓÃÓÚ²¿·ÖÏû»¯µÄ RNA ¹ÑºËÜÕËáʱ£¬LC-MS ÔÔòÉÏ»¹¿ÉÒÔÌṩλµãÌØ¶¨ÐÅÏ¢¡£È»¶ø£¬ÕâÖÖ·ÖÎöͨ³£ÐèÒªÊýÊ®µ½Êý°ÙÄɿ˵ÄÖÁÉÙ²¿·Ö´¿»¯µÄ·Ö×Ó£¬Õâ¶ÔÓÚ mRNA À´ËµÊDz»ÏÖʵµÄ£¬ÒòΪËü¾ßÓи߶ÈÒìÖÊÐԺ͵ͷá¶È µÄÌØÐÔ¡£
Æä´Î£¬Óë tRNA ºÍ rRNA Ïà±È£¬mRNA ÖÐÐÞÊεÄÏà¶ÔˮƽԽµÍ£¬Òò´Ë½âÊÍ LC-MS ½á¹û±äµÃÔ½À´Ô½À§ÄÑ¡£¼´Ê¹À´×Ը߶ȱí´ïµÄ tRNA ºÍ rRNA µÄµÍˮƽÎÛȾ£¨ÓÀÔ¶ÎÞ·¨ÍêÈ«±ÜÃ⣬¾¡¹ÜËüÃÇ¿ÉÒÔÔÚÒ»¶¨³Ì¶ÈÉÏ»ùÓÚ tRNA ÌØÒìÐÔ»ò rRNA ÌØÒìÐÔºËÜÕ½øÐйÀ¼Æ£©£¬Ò²¿ÉÄܵ¼Ö¶ÔmRNAÐÞÊÎˮƽµÄ¸ß¹À¡£m6A ÊÇ MS ¹ã·º½øÐеĵÚÒ»¸ömRNA ÐÞÊηÖÎö£¬ÔÚÕâ·½ÃæÊ©¼ÓµÄÏÞÖÆ½ÏÉÙ£¬ÒòΪËüÔÚ mRNA Öи߶ȷḻ£¬µ«ÔÚ tRNA Öв»´æÔÚ£¬²¢ÇÒ½ö´æÔÚÓÚ rRNA ÖеÄÁ½¸öλµã£¨Òò´Ë£¬ÎÛȾ¿ÉÄܵ¼Öµ͹Àʵ¼Ê m6A ˮƽ£©¡£
Ïà±È֮ϣ¬¾ø´ó¶àÊý·Ç m6A ±í¹Ûת¼×éÔÚ mRNA Öж¼·Ç³£º±¼û£¬ÔÚ tRNA ºÍ rRNA1 ÖиüΪÆÕ±é£¬ÕâÑÏÖØÏÞÖÆÁË LC-MS Á˽âÆä·á¶ÈºÍ¶¯Ì¬µÄÄÜÁ¦¡£ÔÚһЩÇé¿öÏ£¬Í¨¹ý LC-MS ¹À¼ÆµÄÐÞÊηá¶È£¨»ùÓÚ¸ÃÐÞÊα»ÈÏΪÔÚ mRNA ÖÐÒÔ¸ßˮƽ´æÔÚ£©ºÍ»ùÓÚ»ùÒò×é·½·¨£¨Í¨³£ÎÞ·¨¼ì²â mRNA ÖеĴóÁ¿ÐÞÊΣ©£»Òò´Ë£¬ÕâЩ²îÒìµÄ¸ùÔ´¿ÉÄÜÔÚÓÚ mRNA ²¿·ÖÖÐµÄ tRNA »ò rRNA ÎÛȾÎï¡£ÁíÒ»ÖÖ¿ÉÄÜÐÔÊÇijЩÐÞÊÎÊÇ RNA ËðÉ˵Ľá¹û£¬Õâ¿ÉÄܵ¼ÖºËÜÕËáµÄÍé»ù»¯ºÍÑõ»¯¡£ÕâÖÖËæ»úÉ¢²¼ÔÚÕû¸öת¼×éÖеķÇø´ÙÐÞÊοÉÒÔͨ¹ý LC-MS ¼ì²âµ½£¬µ«²»ÄÜͨ¹ý»ùÒò×é·½·¨¼ì²âµ½£¬ÕâÐèÒªÔÚÌØ¶¨Î»µã»ýÀÛÐźš£
¢Û»ùÓÚ²âÐòµÄ·½·¨
ÔÚ¹ýȥʮÄêÖУ¬»ùÓÚ¸ßͨÁ¿²âÐò·ÖÎö¸÷ÖÖÐÞÊÎÒѾ³ÉΪÁ˸ÃÁìÓò½ø²½µÄ¹Ø¼üÇý¶¯Á¦¡£ÕâЩ·½·¨¿ÉÒÔ¸æÖª mRNA ÖÐÐÞÊεĴæÔÚ¼°ÆäÔÚת¼×éÖеľ«È·Î»Öá£
Óë LC-MS Ïà±È£¬ÔÔòÉϵ¥¸ö¹¤×÷Á÷³Ì¾Í¿ÉÒÔ»ñÖªËùÓÐÐÞÊεķá¶È£¬¶øÊ¹ÓûùÒò×é·½·¨Ê¶±ðÐÞÊÎÐèҪΪÿ¸öÐÞÊοª·¢×¨ÓÃÇÒ¶ÀÌØµÄ¹¤×÷Á÷³Ì¡£ÕâÖÖ·½·¨ÐèÒª¿Ë·þµÄ¸ù±¾ÌôÕ½ÊÇ£¬´ó¶àÊýÐÞÊÎÔÚ±ê×¼²âÐòÖÐÊÇ¡°²»¿É¼ûµÄ¡±£¬Ò²¾ÍÊÇ˵£¬ËüÃÇÔÚ½« RNA Äæ×ªÂ¼Îª cDNA ºó²»»áÁôÏÂÈκκۼ££¬ÕâÊÇ»ùÓÚ Illumina µÄ±ê×¼²âÐòµÄÏȾö²½Öè·½·¨¡£Òò´Ë£¬¿ÆÑ§¼ÒÃÇÒѾ¿ª·¢ÁËÒ»Ì×·½·¨À´³ÊÏÖ²»Í¬µÄ¿É¼ûÐ޸ġ£¶ÔÓÚ m6A£¬Ö÷Òª¼ì²â·½·¨ÒÀÀµÓÚ¿¹ m6A ¿¹Ì壬ÕâЩ¿¹ÌåÓÃÓÚÑ¡ÔñÐÔÃâÒß³Áµíº¬ÓÐ m6A µÄ¶Ì RNA Ƭ¶Î¡£
¾¡¹ÜÃâÒß³ÁµíÊÇÒ»ÖÖͨÓ÷½·¨£¬ÔÔòÉÏ¿ÉÒÔÓÃÓÚ¼ì²âÈκÎÐÞÊΣ¬µ«Êµ¼ÊÉÏ£¬»ùÓÚ¿¹ÌåµÄ·½·¨ÔÚ»æÖÆ·Ç m6A ±í¹Ûת¼×éµÄͼÆ×·½ÃæµÄЧÓÃÏ൱ÓÐÏÞ¡£Ôø¾Ñо¿ÈËÔ±³¢ÊÔʹÓÃËüÀ´»æÖÆ m1A »ò ac4C36 µÄͼÆ×£¬ÏÖÔÚ±»ÈÏΪ»áµ¼Ö´óÁ¿¼ÙÑôÐÔλµã£¬Õâ¿ÉÄÜÊÇÓÉÓÚ¿¹Ìå½»²æ·´Ó¦Ôì³ÉµÄ¡£¿¹ m6A ¿¹ÌåÒ²´æÔÚÕâÖÖ½»²æ·´Ó¦ÐÔ£»È»¶ø£¬¼øÓÚ m6A µÄ·á¶ÈÏà¶Ô½Ï¸ß£¬ÐÅÔë±ÈÈÔÈ»¿É¿Ø¡£Ïà±È֮ϣ¬ÒԽϵÍÊýÁ¿¼¶µÄ·á¶È´æÔÚµÄÐÞÊε¼Ö·ÇÌØÒìÐÔÓëÌØÒìÐÔ½áºÏʼþµÄ±ÈÂʼ±¾çÔö¼Ó¡£
Òò´Ë£¬¶ÔÓÚ¾ø´ó¶àÊý·Ç m6A ±í¹Ûת¼×飬ÒѾ¿ª·¢³öÀûÓÃÐÞÊμî»ùµÄ¶ÀÌØ»¯Ñ§ÐÔÖÊʹËüÃÇÔÚÄæ×ªÂ¼ºó¿É¼ûµÄ·½·¨¡£ÕâÊÇͨ¹ý²»Í¬µÄ²ßÂÔʵÏֵģ¬ÀýÈ磬ͨ¹ý¸Ä±äÐÞÊμî»ùÉí·ÝµÄÐÞÊÎÌØÒìÐÔ»¯Ñ§ÎïÖÊ»òͨ¹ý½«´óÁ¿²Ð»ùÌØ¶¨Á¬½Óµ½ÐÞÊμî»ùÉϵ¼ÖÂÄæ×ªÂ¼¹ý³ÌÖйýÔç½Ø¶Ï£¨¼ûÏÂ±í£©¡£ÕâЩʵÑé·½°¸Í¨³£»áµ¼ÖÂÐÞ¸ÄλµãµÄ´íÅä»òȱʧ£¬»òÕßµ¼Ö¶ÁÈ¡µÄ¡°¶Ñ»ý¡±£¬ÕâЩ¶ÁȡѡÔñÐÔµØÔÚÌØ¶¨Î»ÖÿªÊ¼»ò½áÊø£¬È»ºó¿ÉÒÔ´ÓÖÐÍÆ¶Ï³öÐ޸ĵĴæÔÚ¡£´ËÀ໯ѧ»ùÒò×éѧ·½·¨µÄÖ÷ÒªÓÅÊÆÔÚÓÚÆä³öÉ«µÄ¡¢Í¨³£Îªµ¥ºËÜÕËáµÄ·Ö±æÂÊ£¬ÒÔ¼°ËüÃÇÄܹ»ÌṩÐÞÊÎˮƽµÄÏà¶Ô¶¨Á¿£¬ÓÐʱÉõÖÁÊǾø¶Ô¶¨Á¿[1]¡£
±ÈÈ翵³ÉÉúÎィÁ¢ÁËÒ»ÖÖ¸ßÁéÃôµÄ¾ø¶Ô¶¨Á¿µÄʵʱӫ¹â¶¨Á¿pCR¶¨Á¿·ÖÎö·½·¨£¬¿ÉÒÔÔÚµ¥ºËÜÕËá·Ö±æÂÊˮƽÉÏ׼ȷ¼ì²âRNAÖÐm6AÐÞÊÎλµã, ²¢¶Ôδ֪ģ°å½øÐж¨Á¿·ÖÎö¡£¸Ã·½·¨¿É³É¹¦µØÓ¦ÓÃÓÚʵ¼ÊÉúÎïÑùÆ·ÖÐm6AÐÞÊεľ«È·¼ì²â£¬¼´Ê¹Êǵͷá¶ÈRNAµÄÑù±¾¡£
Ë÷È¡¿µ³ÉArraystar m6Aµ¥¼î»ù·Ö±æÂÊоƬ¼¼Êõ×ÊÁÏ>>
½üÄêÀ´Ò²ÓÐһЩеIJâÐò¼¼ÊõÂ½Ðø³öÏÖ£¬±ÈÈç2017 Ä꣬±±¾©´óѧÒÁ³ÉÆ÷¿ÎÌâ×éºÍÒÔÉ«ÁÐκ´ÄÂüÑо¿ËùµÄÑо¿ÍŶӷֱð¶ÀÁ¢±¨µÀÁ˵¥¼î»ù·Ö±æÂÊˮƽ¼ì²â m1A µÄз½·¨¡ª¡ªm1A-MAp ºÍm1A-Seq¡£2019 Ä֥꣬¼Ó¸ç´óѧ Bryan C£® Dickinson ÍŶÓÓëºÎ´¨ÍŶӺÏ×÷£¬Ñо¿¿ª·¢Á˿ɿìËÙÑ¡ÔñÄæ×ªÂ¼Ã¸µÄ½ø»¯Æ½Ì¨£¬²¢ÀûÓÃ¸ÃÆ½Ì¨Ñо¿ mRNA É쵀 m1A ÐÞÊΣ¬ÊµÏÖÁ˵¥¼î»ùˮƽ m1A µÄ¼ì²â¡£
ÁíÍ⣬ֱ½ÓµÄRNAÄÉÃ׿ײâÐòÒ²±¸ÊܹØ×¢£¬RNA±í¹ÛÒÅ´«Ñ§µÄÏÈÇýÈËÎï¡¢¿µÄζû´óѧµÄChristopher Mason±íʾ£¬¡°¹ýÈ¥£¬ÎÒÃÇͨ³£ÊÇÀûÓÿ¹Ìå»ò»¯Ñ§·ÖÎöÀ´ÍƶÏRNAµÄÐÞÊÎ״̬¡£Ö±µ½×î½ü£¬ÎÒÃDzſªÊ¼½øÐÐÖ±½ÓµÄRNA²âÐò¡£ÀûÓÃÄÉÃ׿ײâÐòÒÇ£¬ÎÒÃÇÄܹ»Ö±½Ó²âÐòRNA£¬¶ø²»ÐèÒªÄæ×ªÂ¼¡£ÎÒÃǵÚÒ»´ÎÖ±½Ó²â¶¨RNAÐÞÊΣºÕû¸ö·Ö×Ó´æÔÚÄÄЩÐÞÊΣ¬ÓÖ´æÔÚÄÄЩÒì¹¹Ìå¡£¡±
ËùÒÔ¿ÉÒÔ˵£¬ÄÉÃ׿ײâÐòÄÜÍêÕû²âÐò£¬¶Á³öRNAÐòÁеÄm6A,m5CÐÞÊΣ¨Ò»°ãÊǶÁÈ¡µ¥·Ö×ÓÐòÁÐʱ±ÈÎÞÐÞÊμî»ùÓÐÑÓ³Ù£©£¬¶Á³¤ÓÅÊÆÊ¹Ö®¶Ô¿É±ä¼ôÇÐÑо¿ºÍÒì¹¹Ìå¸üÓÐÓÅÊÆ£¬²»ÓÃÆ´½Ó£¬Ò²²»ÈÝÒ×¶ªÊ§º±¼û·Ö×Ó£¬µ«ÊǾÍÊÇ·ÑÓñȽϹó¡£
ÔÚ×î½üµÄһƪÈȵãÎÄÕ¡°The Architecture of SARS-CoV-2 Transcriptome SARS-CoV-2¡±ÖУ¬Ñо¿ÈËÔ±¾ÍÓÃMinIONÄÉÃ׿ײâÐòÒǽøÐÐÁËDRS²âÐò£¬»ñµÃÁË879,679¸öreads£¨1.9 Gb£©£¬½á¹û²»½öÖ¤Ã÷Á˲¡¶¾×ªÂ¼±¾Õ¼¾ÝÖ÷µ¼µØÎ»£¬¶øÇÒÄÉÃ׿×DRS»ùÓÚRNAµÄµ¥·Ö×Ó¼ì²â£¬ÌṩÁ˶ÀÌØµÄ»ú»áÀ´¼ì²éµ¥¸öRNA·Ö×ӵĶà¸öת¼×éÌØÕ÷£¬½âÎöÁËйڲ¡¶¾RNAÐÞÊÎÌØµã[9]¡£
¢ÆÄ¿Ç°ÒÑÖªµÄRNA±í¹Ûת¼ÐÞÊΣº
m6A
m6AÊÇÕæºËÉúÎïmRNAÉϺ¬Á¿×î·á¸»µÄ»¯Ñ§ÐÞÊΣ¬Óɼ׻ù×ªÒÆÃ¸¸´ºÏÎ°üº¬METTL3£¬METTL14£¬WTAp£¬KIAA1429£¬RBM15£¬RBM15B£©´ß»¯²úÉú£¬¿É±»È¥¼×»ù»¯Ã¸ALKBH5»òFTOÈ¥³ý¡£Ä¿Ç°ÒÑ·¢ÏÖÁ˶àÖÖÌØÒìÐÔʶ±ðm6AλµãµÄµ°°×»ò¸´ºÏÎ°üÀ¨YTH¼Ò×åµ°°×£¨YTHDF1-3£¬YTHDC1£©¡¢×ªÂ¼Æðʼ¸´ºÏÎïeIF3¡¢ºËÌǺ˵°°×£¨HNRNpA2B1£¬HNRNpC£©ÒÔ¼°RNA½áºÏµ°°×SRSF2¡£m6AÖ÷Òª·Ö²¼ÔÚÖÕÖ¹ÃÜÂë×Ó¸½½üºÍ3¡¯UTRÇø£¬Ó°ÏìRNAÅä¶Ô¡¢¸Ä±äRNA¶þ¼¶½á¹¹¡¢»ò±»µ°°×Ö±½Óʶ±ð£¬½ø¶øµ÷¿ØmRNAµÄ³ÉÊì¡¢¿É±ä¼ô½Ó¡¢Îȶ¨ÐԺͷÒë¹ý³Ì¡£ÓëA-UÅä¶ÔÏà±È£¬m6A-UÅä¶Ô½Ï²»Îȶ¨£¬Òý·¢RNAÄÚ²¿Ë«Á´½âÐýÓë¶þ¼¶½á¹¹×ª±ä¡£m6A³£ÔÚË«Á´Óëµ¥Á´µÄ¹ý¶ÉÇøÓò¶Ñµþ£¬ÔöÇ¿RNAת±äºó¹¹ÏóµÄÎȶ¨ÐÔ¡£È¥¼×»ù»¯Ôò¿ÉÒÔʹmRNA»Ö¸´ÔÀ´¹¹Ïó¡£ÕâÖÖ¹¹Ïóת±ä¿ÉÄܵ¼ÖÂmRNAÓ벻ͬµ°°×µÄÏ໥×÷Óøı䣬´Ó¶ø²úÉú²»Í¬µÄÉúÎïѧЧӦ¡£m6AÄÜÖ±½Ó±»Ìض¨µ°°×µÄÊèË®½á¹¹ÓòËùʶ±ð¡£±ÈÈ磬YTH¼Ò×åµ°°×¿ÉÒÔÌØÒìÐÔµÄʶ±ðm6A£¬ÌرðÊÇGGm6ACU±£ÊØÐòÁС£Æä³ÉÔ±Ö®Ò»YTHDC1ʶ±ð²¢½áºÏm6A£¬µ÷¿Ø°ÐÏòmRNAµÄ¿É±ä¼ô½Ó¡£¶øÁíÒ»³ÉÔ±YRHDF2Óëm6A½áºÏºó£¬ÕÐļCCR4-NOT¸´ºÏÎ´Ù½ø°ÐÏòRNAµÄ½µ½â¡£ÔÚUV·øÉä»òÈÈÐݿ˷´Ó¦ÖУ¬×ªÂ¼Æðʼ¸´ºÏÎïeIF3Óë5¡¯UTRÇøµÄm6A½áºÏ£¬´Ù½øÃ±·ÇÒÀÀµµÄ·Òë¹ý³Ì¡£±àÂëÇøµÄm6A¿É±»SRSF2ʶ±ð£¬²ÎÓëÖ¬·¾Éú³ÉµÄµ÷¿Ø¡£ÔÚ¹ûÓ¬ÖУ¬YTHDC1ͬԴµ°°×ʶ±ðÐÔ±ðÖÂËÀmRNAÉϵÄm6Aλµã£¬µ÷¿ØÆä¿É±ä¼ô½Ó£¬´Ó¶ø¿ØÖƹûÓ¬µÄÐÔ±ð¡£ÈçǰËùÊö£¬m6A½éµ¼µÄmRNAÎȶ¨ÐÔµ÷½ÚÒ²¶Ô¸Éϸ°û·Ö»¯ÓëÉúÎï½ÚÂÉʱÖÓ¿ØÖÆÊ®·ÖÖØÒª¡£´ËÍ⣬m6AÒ²ÄÜͨ¹ýÓ°ÏìmRNAÓëtRNA·´ÃÜÂë×ÓµÄÅä¶ÔËÙÂÊÓë±£Õæ¶È£¬´Ó¶øÓ°Ïì·ÒëÑÓÉì¡£
Ñо¿·½·¨·½Ã棬Arraystar m6Aµ¥¼î»ù·Ö±æÂÊоƬÀûÓÃRNAøMazF¶Ôm6AÃô¸ÐµÄÌØÐÔ£¬¿ÉÔÚµ¥¼î»ù·Ö±æÂÊˮƽ¶¨Î»m6Aλµã£¬²¢¶ÔÆä½øÐж¨Á¿¡£¸ÃоƬ¾ßÓÐÆäËüÏÖ´æ¼¼ÊõÄÑÒÔÆó¼°µÄÓÅÊÆ£¬ÊÇÑо¿m6A¶¯Ì¬±ä»¯¡¢ÉúÎïѧ¹¦ÄÜÒÔ¼°¼²²¡Ïà¹ØÐÔµÄÇ¿´ó¹¤¾ß¡£
m1A
m1AÊÇнü·¢ÏֵĿÉÄæµÄ±í¹Ûת¼ÐÞÊΣ¬Äܱ»RNAÐÞ¸´Ã¸ALKBH3È¥³ý£¬Ä¿Ç°ÉÐδ·¢ÏÖÃ÷È·µÄm1AÐÞÊÎøÓëÐÞÊÎʶ±ðµ°°×¡£Óëm6A²»Í¬£¬m1AµÄ±í´ï·á¶È½ÏµÍ£¬Ö÷Òª·Ö²¼ÔÚmRNAµÄ5¡¯UTRÇø£¬¿ÉÄܲÎÓëµ÷½Ú·ÒëÆðʼ¹ý³Ì¡£m1AÄÜÍêÈ«×èÖ¹Watson-CrickÅä¶Ô£¬ÒýÆðRNAË«Á´½âÐý£¬²¢´Ù½øRNA-µ°°×µÄ¾²µçÏ໥×÷ÓûòRNA¿É±ä¶þ¼¶½á¹¹µÄÐγɡ£m1AµÄÉúÎïѧ¹¦ÄÜÈÔÊôδ֪¡£ÓÐÑо¿·¢ÏÖ£¬ÔÚÈÈÐݿ˻òÓªÑøØÑ·¦µÈѹÁ¦Ìõ¼þÏ£¬Ï¸°ûÄÚµÄm1A±í´ïˮƽÉÏÉý£¬¿ÉÄÜÊÇͨ¹ý´Ù½øÃ±ÒÀÀµÐÔ·Ò룬²ÎÓëϸ°ûµÄÓ¦¼¤·´Ó¦¡£
m5CÓëhm5C
m5C¹ã·º·Ö²¼ÓÚtRNAÓërRNAÉÏ£¬¾ßÓÐÎȶ¨tRNA¶þ¼¶½á¹¹¡¢Ó°Ïì·´ÃÜÂë×Ó»·¹¹Ïó¡¢Î¬³ÖrRNA·Òë±£ÕæµÈ¹¦ÄÜ¡£Ð½üµÄRNA²âÐò½á¹û·¢ÏÖ£¬mRNAµÄ±àÂëÇøÓë·Ç±àÂëÇøÉÏ´æÔÚ8000¶à¸öm5Cλµã£¬¶øÇÒÏ൱һ²¿·Öλµã¼¯ÖÐÔÚ5¡¯UTRÓë3¡¯UTRÇø¡£m5C¿ÉÓɼ׻ù×ªÒÆÃ¸NSUN2»òTRDMT1´ß»¯Ðγɣ¬±»Ë«¼ÓÑõøTETÑõ»¯ÐγÉhm5C¡£hm5C¿ÉÄܾ¹ý½øÒ»²½Ñõ»¯ÐγÉf5C£¬½ø¶ø±ä»Ø°ûà×ऺËÜÕ£¨C£©¡£m5C²»Ó°Ïì¼î»ùÅä¶Ô£¬µ«¿ÉÄÜÔöÇ¿¼î»ù¶ÑµþÒÔ¼°RNAÓëµ°°×µÄÊèË®×÷Óá£m5C¾ßÓжàÖÖÉúÎïѧ¹¦ÄÜ¡£p16 mRNAÔÚ±»NSUN2øÌí¼Óm5CÐÞÊÎºó£¬Æä½µ½â±»ÒÖÖÆ£¬Îȶ¨ÐÔÔöÇ¿¡£ÔÚϸ°ûÖÜÆÚÖУ¬NSUN2µÄ±í´ïÊܵ½¾«Ãܵ÷¿Ø¡£NSUN2¿ÉÔÚCDK1 3¡¯UTRÇøÌí¼Óm5CÐÞÊΣ¬´Ù½øÆä·Ò룻ͬʱÔÚCDKN1BµÄ5¡¯UTRÇøÌí¼Óm5CÐÞÊΣ¬ÒÖÖÆCDKN1BµÄ·Òë¡£¶þÕß¹²Í¬×÷Óã¬Ôöǿϸ°ûµÄÔöÖ³ÄÜÁ¦¡£m5C»¹ÓëË¥ÀÏÏà¹Ø»ùÒòµÄ·Òë¿ØÖÆÓйأ¬¹ý±í´ïNSUN2¿ÉÒÔÑÓ»º¸´ÖÆÐÔË¥Àϵķ¢Éú¡£×÷Ϊm5CµÄÑõ»¯²úÎhm5CÒ²ÄÜÔöÇ¿·ÒëЧÂÊ¡£hm5CÔÚ¹ûÓ¬µÄÄÔÖбí´ïÁ¿ºÜ¸ß£¬¿ÉÄܲÎÓë¹ûÓ¬µÄÄÔ²¿·¢Óý¡£
pseudouridine (¦×)
¼ÙÄòà×ऺËÜզף¬³£±»³ÉΪµÚÎåÀàºËÜÕËᣬÓÉÄòà×ऺËÜÕ£¨U£©Òì¹¹»¯Ðγɡ£ÔÚÈ˵Äϸ°ûºÍСÊó×éÖ¯µÄmRNAÖУ¬¦×/UµÄ±ÈÂÊԼΪ0.2-0.6%¡£Äòà×à¤Óë¼ÙÄòà×वÄÒì¹¹»¯·´Ó¦ÓÉpUSøµ¥¶À£¬»òÓëH/ACAºËÌǺ˵°°×Ò»Æð£¬´ß»¯Íê³É¡£¼ÙÄòà×à¤ÄܼõÉÙRNA¹¹ÏóµÄ¿É±äÐÔ£¬ÔöÇ¿¼î»ùÅä¶ÔÎȶ¨ÐÔÒÔ¼°Óëµ°°×Ö®¼äµÄµÄ¼«ÐÔÏ໥×÷Ó᣼ÙÄòà×िÉÄܵ÷¿ØmRNAÎȶ¨ÐԺͻùÒò±í´ï£¬²ÎÓë½ÍĸµÄÈÈÐݿ˷´Ó¦£¬µ«¾ßÌå»úÖÆÄ¿Ç°Éв»Ã÷È·¡£
Inosine (I)
¼¡ÜÕÐÞÊΣ¬³£³ÆÎªA-to-I±à¼£¬ÊǸߵÈÕæºËÉúÎïÀï×î³£¼ûµÄÒ»ÖÖRNA±à¼·½Ê½£¬ÓÉÏÙÜÕËáÍѰ±Ã¸ADARÍê³É¡£A-to-I±à¼Ö÷Òª·¢ÉúÔڷDZàÂëÇø»òÄÚº¬×ÓÇøµÄAluÔªËØÄÚ¡£A-to-I±à¼ÍêÈ«¸Ä±äÁ˼î»ùÅä¶ÔÌØÐÔ£¬AUÅä¶Ôת±äΪICÅä¶Ô£¬´Ó¶ø¸Ä±äËù±àÂëµÄ°±»ùËá¡£±ÈÈ磬A-to-I±à¼½«´óÄԹȰ±ËáÊÜÌåÖеĹȰ±õ£°·ÖرàÂëΪ¾«°±Ëᣬµ¼ÖÂÁ˸ÆÀë×Óͨ͸ÐԵĸı䡣´ËÍ⣬A-to-I±à¼»¹¾ßÓиıä¿É±ä¼ô½Ó¡¢µ÷½ÚmiRNAµÄ²úÉúÓ빦ÄÜ¡¢ÒÔ¼°¼à¿ØÏÈÌìÐÔÃâÒß·´Ó¦µÈ×÷Óá£
ac4C
2018Ä꣬ÃÀ¹úNIHµÄShalini Oberdoerffer½ÌÊÚÔÚCell·¢±íÑо¿ÂÛÎÄ£ºAcetylation of Cytidine in mRNA promotes Translation Efficiency£¬Ê״νÒʾmRNAÉÏ´æÔÚ´óÁ¿ac4CÐÞÊΣ¬²¢ÇÒac4CÓ°ÏìmRNAµÄÎȶ¨ÐÔÓë·ÒëЧÂÊ¡£
N4-acetylcytidine (ac4C)£¬N4λÒÒõ£°ûà×ण¬ÊÇÕæºËÔºËÉúÎïÖб£ÊصĻ¯Ñ§ÐÞÊΣ¬ÔçÆÚÑо¿ÈÏΪac4CÖ÷Òª´æÔÚtRNAºÍ18S rRNAÉÏ¡£¶ø½üÆÚÑо¿ÏÔʾ£¬mRNAÉÏÒ²´æÔÚ´óÁ¿µÄac4C£¬Æä·á¶ÈÉõÖÁ²»µÍÓÚmRNAЯ´øµÄm7Gñ×ÓÐÞÊΡ£NAT10ÊÇĿǰ¼ø¶¨µÄΨһͬʱ¾ßÓÐÒÒõ£»¯Ã¸½á¹¹ÓòºÍRNA½áºÏ½á¹¹ÓòµÄµ°°×£¬Òò´Ë±»ÈÏΪÊÇRNA ac4CÐÞÊÎø¡£
ÓÉ´Ë£¬ÒÒõ£»¯×÷ΪһÀàÐ嵀 mRNA ÐÞÊΣ¬½«±í¹Ûת¼×éÀ©Õ¹µ½ÒÑÖªÀà±ðµÄ¼×»ù»¯ºÍÒì¹¹»¯Ö®Íâ¡£ÕâЩ¹¤×÷»¹À©Õ¹ÁË mRNA ÐÞÊεÄÒÑÖª¿â£¬²¢È·¶¨Á˶àÖÖ»¯Ñ§ÐÞÊεĴæÔÚ£¬mRNA ÐÞÊεÄÐÂģʽÔÚδÀ´ºÜ¿ÉÄÜ»á¼ÌÐø³öÏÖ¡£½øÒ»²½Á˽âÕâЩÐÞÊεŦÄÜ¡¢µ÷½ÚËüÃÇÔÚÌØ¶¨×ªÂ¼±¾ÉϵĴæÔÚµÄ;¾¶ºÍ»úÖÆ£¬ÒÔ¼°ËüÃÇÔÚ¸÷ÖÖÉúÀíºÍ¼²²¡±³¾°ÏµĹ¦ÄÜ£¬½«ÓÐÖúÓÚ¸üÈ«ÃæµØÁ˽â±í¹Ûת¼×éÔÚ»ùÒò±í´ïÖеÄ×÷ÓÃ[6]¡£
TGMÐÞÊÎ
5¡¯¶Ë³¬¼×»ù»¯µÄTMGÐÞÊÎÊÇ×îÔç±»·¢ÏÖµÄÐÞÊÎÖ®Ò»¡£ÔÚÐí¶à±»RNA¾ÛºÏøIIת¼µÄRNAÖУ¬ÓÈÆäÊǷDZàÂëRNA£¬ÀýÈç¼ô½ÓÌåµÄÖØÒª×é³É³É·ÖsnRNA£¬5¡¯¶ËµÄm7G¼×»ùñ×ӻᱻ³¬¼×»ù»¯£¬ÐγɾßÓÐÈý¸ö¼×»ùµÄN2, N2, 7-Èý¼×»ùÄñÜÕ£¨TMG£©Ã±×Ó£¬¹ã·º´æÔÚÓÚÕæºËÉúÎïÖС£Èý¼×»ùÄñÜպϳÉø£¨Tgs1£©ÔÚÐí¶àÉúÎïÌåÖÐÒѾ±»Ö¤ÊµÊǺϳÉTMGñ×ÓµÄΨһ¼×»ùø£¬ÔÚ½ø»¯ÉÏ´Ó½Íĸµ½ÈËÀà¶¼ºÜ±£ÊØ¡£ÓÉÓÚÌåÍâʵÑéµÄ¾ÖÏÞÐÔ£¬TMGÐÞÊζԼô½ÓÌåRNAµÄµ÷¿Ø»úÖÆ»¹´æÔںܶ಻Çå³þµÄµØ·½£¬²¢ÇÒÔÚ´ó¶àÊý¶àϸ°ûģʽÉúÎïÖж¼ÎÞ·¨Ö±½Ó´ÓÌåÄÚ¶ÔTMGÐÞÊνøÐÐÑо¿£¬Òò´Ë£¬TMGÐÞÊÎÒѾ±»·¢ÏÖÁËÎåÊ®¶àÄ꣬µ«ÊÇÆäÔÚ¶àϸ°ûÉúÎïÖеŦÄܲ¢²»Ã÷È·¡£
£¨ÉúÎïͨ£ºÍòÎÆ£©
²Î¿¼ÎÄÏ×£º
1. The epitranscriptome beyond m6A,Nature Reviews Genetics volume 22, pages119¨C131 (2021)
2. Epitranscriptome sequencing technologies: decoding RNA modifications,Nature Methods volume 14, pages23¨C31 (2017)
3. Detecting RNA modifications in the epitranscriptome: predict and validate,Nature Reviews Genetics volume 18, pages275¨C291 (2017)
4. RNA editing-dependent epitranscriptome diversity in cancer stem cells,Nature Reviews Cancer volume 17, pages381¨C392 (2017)
5. RNA modifications: what have we learned and where are we headed? Nature Reviews Genetics volume 17, pages365¨C372 (2016)
6. mRNA acetylation: a new addition to the epitranscriptome£¬p. Cody He & Chuan He Cell Research volume 29, pages91¨C92 (2019)
7. Wendy V. Gilbert, Tristan A. Bell, Cassandra Schaening. Science (2016)
8. Cole J.T. Lewis, Tao pan, Auinash Kalsotra. Nat Rev Mol Cell Biol (2017)
9. The Architecture of SARS-CoV-2 Transcriptome,Cell,April 23£¬2020